THE 23RD ANNUAL SAMUEL WAXMAN CANCER COLLABORATING FOR A CURE GALA

Waxman Gala

 The 23rd Annual Collaborating for a Cure Gala, one of New York City’s much-anticipated Autumn charity events, this year will feature a virtual musical retrospective of 23 years of the gala with celebrity appearances. The event will support the groundbreaking research of the Samuel Waxman Cancer Research Foundation (SWCRF) and honor Roger A. Krone, Chairman and Chief Executive Officer, Leidos, on Thursday, November 19, 2020, at 7:00 PM. 

The gala will feature appearances by SWCRF Board Chairman Michael Nierenberg, Founder and CEO Dr. Samuel Waxman, Honoree Roger Krone, and a surprise guest host. This year, quests can enjoy virtually all the favorite things they like from the Waxman Gala, including music, comedy, and entertainment. The gala preshow will start at 6:30 PM and will include music, an online journal with messages from supporters, and other messages. This will be followed by a show starting at 7:00 PM.

 The show will feature comedy, exciting performances from some of your favorite stars, special appearances, and a presentation of the Samuel Waxman Cancer Research Foundation award to honoree Roger A. Krone, Chairman and Chief Executive Officer of Leidos. This event will be a lively and entertaining experience and a retrospective of 23 years of the Collaborating for a Cure Waxman Gala. The gala can be viewed on a Smart TV, desktop PC, or MAC, laptop, or tablet/iPad with a connection to Wi-Fi, from wherever you may be, along with family, friends, or even your beloved pet and of course, your favorite beverage. For more information about the 23rd Annual Collaborating for a Cure Gala, visit www.waxmancancer.org/events/waxman-gala.

 About Roger A. Krone: 

 Roger A. Krone is Chairman and Chief Executive Officer of Leidos. With approximately $11 billion in annual revenue and 38,000 employees worldwide, Leidos is a recognized global leader in solving important problems in the defense, intelligence, homeland security, civil, and health markets. Before being named CEO in July 2014, Krone held leadership roles at some of the most prominent organizations in aerospace for nearly 40 years. For Krone, the future of Leidos is one with a laser focus on its customers, shareholders, and employees. In 2016, Krone engineered Leidos’ return to growth through major program wins, and mergers and acquisition activity. This included the acquisition of Lockheed Martin’s Information Systems & Global Solutions business, among others. Under his strategic vision, the organization remains committed to fostering a culture of innovation and investing in critical internal research and development efforts. Krone is a member of the Georgia Tech Foundation Board of Trustees, WETA Public Television and Radio in Washington board, the Greater Washington Urban League chapter board, the Business Roundtable, and the Aircraft Owners and Pilots Association (AOPA) Foundation’s Board of Advisors. He serves as the chair of the Professional Services Council (PSC), and is a member of the Executive Committee of the Aerospace Industries Association (AIA). 

About Samuel Waxman Cancer Research Foundation: 

 The Samuel Waxman Cancer Research Foundation is an international organization dedicated to curing and preventing cancer. The Foundation is a pioneer in cancer research and its mission is to eradicate cancer by funding cutting-edge research that identifies and corrects abnormal gene function that causes cancer and develops minimally toxic treatments for patients. Through the Foundation’s collaborative group of world-class scientists, the Institute Without Walls, investigators share information and tools to speed the pace of cancer research. Since its inception in 1976, the Samuel Waxman Cancer Research Foundation has awarded more than $100 million to support the work of more than 200 researchers across the globe. For more information about the SWCRF research.